ONC Mandatory Disclosures

The Medicare and Medicaid Electronic Health Records (EHR) Incentive Programs will provide incentive payments to eligible professionals and eligible hospitals as they demonstrate adoption, implementation, upgrading, or meaningful use of certified EHR technology. These incentive programs are designed to support providers in this period of Health IT transition and instill the use of EHRs in meaningful ways to help our nation to improve the quality, safety, and efficiency of patient health care.

Meaningful Use Resources

Stay informed and educated on the most current information on Meaningful Use criteria, economic stimulus package, and government reimbursements:

Azalea Health Drummond Certified – 2015 Edition Modular Certification

Azalea Health’s Azalea EHR version 3.0 was 2015 Stage 3 modular certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 08/10/2017.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Because the Azalea solution is cloud-based and compliant, our customers don’t have to worry about upgrading to a new version.

Unique certification number:

CHPL ID: 15.04.04.2688.Azal.03.1.0.170810

Criteria to which Azalea EHR is certified:

170.315 (a)(11): Smoking Status View
170.315 (a)(12): Family Health History
170.315 (d)(1): Authentication, Access Control, Authorization
170.315 (d)(2): Auditable Events and Tamper-Resistance
170.315 (d)(3): Audit Report(s)
170.315 (d)(4): Amendments
170.315 (d)(5): Automatic Access Time-out
170.315 (d)(6): Emergency Access
170.315 (d)(7): End-User Device Encryption
170.315 (d)(9): Trusted Connection
170.315 (f)(1): Transmission to Immunization Registries
170.315 (f)(2): Transmission to Public Health Agencies – Syndromic Surveillance
170.315 (g)(4): Quality Management System
170.315 (g)(5): Accessibility-Centered Design

Additional software use demonstrate compliance with certification criteria:

none

ONC Disclaimer:

This EHR is 2015 Edition modular compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  

Cost and Limitations:

Azalea Health Drummond Certified – 2014 Edition Complete Certification

Drummond certification complete EHR ambulatory

Azalea Health’s Azalea EHR version 2.1 was 2014 Stage 2 certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 10/08/2015.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Because the Azalea solution is cloud-based and compliant, our customers don’t have to worry about upgrading to a new version.

Unique certification number:

CHPL ID: 10082015-3440-5

Criteria to which Azalea EHR is certified:

170.314(a)(1)  COMPUTERIZED PROVIDER ORDER ENTRY
170.314(a)(3)  DEMOGRAPHICS
170.314(a)(5)  PROBLEM LIST
170.314(a)(6)  MEDICATION LIST
170.314(a)(7)  MEDICATION ALLERGY LIST
170.314(a)(8)  CLINICAL DECISION SUPPORT
170.314(b)(1)  TRANSITIONS OF CARE – RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(2)  TRANSITIONS OF CARE – CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(7)  DATA PORTABILITY
170.314(c)(1)  CLINICAL QUALITY MEASURES – CAPTURE AND EXPORT
170.314(c)(2)  CLINICAL QUALITY MEASURES – IMPORT AND CALCULATE
170.314(c)(3)  CLINICAL QUALITY MEASURES – ELECTRONIC SUBMISSION
170.314(d)(1)  AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
170.314(d)(2)  AUDITABLE EVENTS AND TAMPER-RESISTANCE
170.314(d)(3)  AUDIT REPORT(S)
170.314(d)(4)  AMENDMENTS
170.314(d)(5)  AUTOMATIC LOG-OFF
170.314(d)(6)  EMERGENCY ACCESS
170.314(d)(7)  END-USER DEVICE ENCRYPTION
170.314(d)(8)  INTEGRITY
170.314(g)(4)  QUALITY MANAGEMENT SYSTEM
Clinical Quality Measures to which Azalea EHR is certified:
CMS2  PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL DEPRESSION AND FOLLOW-UP PLAN
CMS22  PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED
CMS50  CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT
CMS52  HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP) PROPHYLAXIS
CMS56  FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT
CMS61  PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED
CMS62  HIV/AIDS: MEDICAL VISIT
CMS64  PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
CMS65  HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE
CMS66  FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT
CMS68  DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD
CMS69  PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
CMS74  PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY PRIMARY CARE PROVIDERS, INCLUDING DENTISTS
CMS75  CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES
CMS77  HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV
CMS82  MATERNAL DEPRESSION SCREENING
CMS90  FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS
CMS117  CHILDHOOD IMMUNIZATION STATUS
CMS122  DIABETES: HEMOGLOBIN A1C POOR CONTROL
CMS123  DIABETES: FOOT EXAM
CMS124  CERVICAL CANCER SCREENING
CMS125  BREAST CANCER SCREENING
CMS126  USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
 CMS127 Met
CMS127  PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
CMS128  ANTI-DEPRESSANT MEDICATION MANAGEMENT
CMS129  PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK PROSTATE CANCER PATIENTS
CMS130  COLORECTAL CANCER SCREENING
CMS131  DIABETES: EYE EXAM
CMS132  CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES
CMS133  CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS FOLLOWING CATARACT SURGERY
CMS134  DIABETES: URINE PROTEIN SCREENING
CMS135  HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
CMS136  ADHD: FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) MEDICATION
CMS137  INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG DEPENDENCE TREATMENT
CMS138  PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION
CMS139  SCREENING FOR FUTURE FALL RISK
CMS140  BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE BREAST CANCER
CMS141  COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON CANCER PATIENTS
CMS142  DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE
CMS143  PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION
CMS144  HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
CMS145  CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)
CMS146  APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
CMS147  PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION
CMS148  HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
CMS149  DEMENTIA: COGNITIVE ASSESSMENT
CMS153  CHLAMYDIA SCREENING FOR WOMEN
CMS154  APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
CMS155  WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
CMS156  USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
CMS157  ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY QUANTIFIED
CMS158  PREGNANT WOMEN THAT HAD HBSAG TESTING
CMS159  DEPRESSION REMISSION AT TWELVE MONTHS
CMS160  DEPRESSION UTILIZATION OF THE PHQ-9 TOOL
CMS161  MAJOR DEPRESSIVE DISORDER (MDD): SUICIDE RISK ASSESSMENT
CMS163  DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
 CMS164 Met
CMS164  ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC
CMS165  CONTROLLING HIGH BLOOD PRESSURE
CMS166  USE OF IMAGING STUDIES FOR LOW BACK PAIN
CMS167  DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY
CMS169  BIPOLAR DISORDER AND MAJOR DEPRESSION: APPRAISAL FOR ALCOHOL OR CHEMICAL SUBSTANCE USE
CMS177  CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER: SUICIDE RISK ASSESSMENT
CMS179  ADE PREVENTION AND MONITORING: WARFARIN TIME IN THERAPEUTIC RANGE.
CMS182  ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL
CQM Domains to with Azalea EHR has been certified:
Care Coordination
Efficient Use of Healthcare Resources  
Patient Safety
Clinical Process/Effectiveness  
Population/Public Health  
Patient & Family Engagement  


Additional software use demonstrate compliance with certification criteria
:

Dr. First
Phimail

ONC Disclaimer:

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  


Cost and Limitations:

Cost and Limitations table for meaningful use page on website

ChartAccess EHR – 2014 Edition Complete Inpatient Certification

Azalea Health’s Inpatient EHR, ChartAccess® 5.0, was 2014 edition certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 06/30/2016.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Unique certification number:

CHPL ID: 14.04.04.2221.Char.05.1.1.160630

 

Criteria to which ChartAccess® is certified:

170.314 (a)(1): Computerized provider order entry
170.314 (a)(2): Drug-drug, drug-allergy interactions checks
170.314 (a)(3): Demographics
170.314 (a)(4): Vital signs, body mass index, and growth Charts  
170.314 (a)(5): Problem list
170.314 (a)(6): Medication list
170.314 (a)(7): Medication allergy list
170.314 (a)(8): Clinical decision support
170.314 (a)(9): Electronic notes
170.314 (a)(10): Drug formulary checks
170.314 (a)(11): Smoking status
170.314 (a)(12): Image results
170.314 (a)(13): Family health history
170.314 (a)(14): Patient list creation
170.314 (a)(15): Patient-specific education resources
170.314 (a)(16): Inpatient setting only – electronic medication administration record
170.314 (a)(17): Advance directives
170.314 (a)(18): Optional – computerized provider order entry – medications
170.314 (a)(19): Optional – computerized provider order entry – laboratory
170.314 (a)(20): Optional – computerized provider order entry – diagnostic imaging
170.314 (b)(1): Transitions of care – receive, display and incorporate transition of care/referral summaries
170.314 (b)(2): Transitions of care – create and transmit transition of care/referral summaries
170.314 (b)(3): Electronic prescribing
170.314 (b)(4): Clinical information reconciliation
170.314 (b)(5)(B): Incorporate laboratory tests and values/results
170.314 (b)(6): Inpatient setting only – transmission of electronic laboratory tests and values/results to ambulatory providers
170.314 (b)(7): Data portability
170.314 (c)(1): Clinical quality measures – capture and export
170.314 (c)(2): Clinical quality measures – import and calculate
170.314 (c)(3): Clinical quality measures – electronic submission
170.314 (d)(1): Authentication, access, control, and authorization
170.314 (d)(2): Auditable events and tamper-resistance
170.314 (d)(3): Audit report(s)
170.314 (d)(4): Amendments
170.314 (d)(5): Automatic log-off
170.314 (d)(6): Emergency access
170.314 (d)(7): End-user device encryption
170.314 (d)(8): Integrity
170.314 (e)(1): View, download, and transmit to a 3rd party with edge protocol testing
170.314 (f)(1): Immunization information
170.314 (f)(2): Transmission to immunization registries
170.314 (f)(3): Transmission to public health agencies – syndromic surveillance
170.314 (f)(4): Inpatient setting only – transmission of reportable laboratory tests and values/results
170.314 (g)(2): Automated measure calculation
170.314 (g)(3): Safety-enhanced design
170.314 (g)(4): Quality management system  

 

Clinical Quality Measures to which ChartAccess® is certified:

CMS9: Exclusive Breast Milk Feeding
CMS26: Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver
CMS30: Statin Prescribed at Discharge
CMS31: Hearing Screening Prior To Hospital Discharge
CMS32: Median Time from ED Arrival to ED Departure for Discharged ED Patients
CMS53: Primary PCI Received Within 90 Minutes of Hospital Arrival
CMS55: Median Time from ED Arrival to ED Departure for Admitted ED Patients
CMS60: Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival
CMS71: Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS72: Antithrombotic Therapy By End of Hospital Day 2
CMS73: Venous Thromboembolism Patients with Anticoagulation Overlap Therapy
CMS91: Thrombolytic Therapy
CMS100: Aspirin Prescribed at Discharge
CMS102: Assessed for Rehabilitation
CMS104: Discharged on Antithrombotic Therapy
CMS105: Discharged on Statin Medication
CMS107: Stroke Education
CMS108: Venous Thromboembolism Prophylaxis
CMS109: Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram
CMS110: Venous Thromboembolism Discharge Instructions
CMS111: Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS113: Elective Delivery
CMS114: Incidence of Potentially-Preventable Venous Thromboembolism
CMS171: Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision
CMS172: Prophylactic Antibiotic Selection for Surgical Patients
CMS178: Urinary catheter removed on Postoperative Day 1 (POD 1) or Postoperative Day 2 (POD 2) with day of surgery being day zero
CMS185: Healthy Term Newborn
CMS188: Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients
CMS190: Intensive Care Unit Venous Thromboembolism Prophylaxis

 

Additional software use demonstrate compliance with certification criteria:

DrFirst Rcopia, Intelichart, ExitCare

 

ONC Disclaimer:

This EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  

Costs & Limitations Transparency:

Upfront costs:

  • Tiered software licensing based on provider or bed quantity at time of purchase
  • Implementation and Training services
  • Basic Support and Maintenance services
  • Hosting or Hardware costs as defined by licensing model


Additional fees which may be incurred include:

  • Training beyond the scope of the original implementation
  • Consulting services for meeting regulatory requirements
  • Level II support services beyond the scope of the licensed product
    • e.g.: infrastructure and network support
  • Maintenance release level updates outside of normal business hours
  • New Software Release Versions which were not included in initial Software licensing
  • New Modular Products not in initial software licensing.
  • New Interface development and maintenance beyond the scope of the original implementation
    • e.g.: interfaces to reporting registries for Meaningful Use measures or any other regulatory reporting
  • Implementation of additional peripheral and other hardware devices beyond the scope of the original implementation
    • e.g.: including but not limited to printers, mobile workstations, scanners, tablets, etc.
  • Prognosis Innovation Healthcare cloud backup solution
  • Software reconfiguration requests outside of the original scope of implementation
  • Revenue Cycle Management services


Costs which may be subject to escalation:

  • Annual support and maintenance fees
  • If applicable, annual hosting fees
  • If applicable, annual subscription fees
  • Annual third party fees such as ePrescribing, Practice Portal, Patient education content, Encoding, Insurance Eligibility and Advanced Beneficiary Notice which may be brokered through Prognosis Innovation Healthcare or contracted directly


Periodic charges for continual right to use of the software:

As defined by licensing model:

  • Tiered subscription pricing based on provider or bed quantity
  • Annual software Support and Maintenance for contracted software licensing

Limitations:

  • Use of the Patient Electronic Access Reporting out of the Patient Portal is limited to the following DirectTrust network HISPs at this time: MaxMD, Nitor Group.
  • If Public Health Reporting is achieved through an HIE then automated measure calculation of this measure may not be possible without new or additional Interface development.
  • Automated measure calculation of Patient Specific Education requires the use of a specific vendor
  • Automated measure calculation of Electronic Prescribing and refill requests requires the use of a specific vendor without a new or additional interface development.
  • On premise Customer facility installations of Prognosis systems must have the ability to connect to the Prognosis datacenter via an Internet connection to access certain features of the system.
  • Customer must establish a Virtual Private Network connection to Prognosis for Support Services to be activated.

ChartAccess EHR – 2014 Edition Complete Ambulatory Certification

Azalea Health’s Ambulatory EHR, ChartAccess® 5.0, was 2014 edition certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 09/25/2014.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

 

Unique certification number:

CHPL ID:  09252014-2367-5

Criteria to which ChartAccess® is certified:

170.314 (a)(1): Computerized provider order entry
170.314 (a)(2): Drug-drug, drug-allergy interactions checks
170.314 (a)(3): Demographics
170.314 (a)(4): Vital signs, body mass index, and growth Charts
170.314 (a)(5): Problem list
170.314 (a)(6): Medication list
170.314 (a)(7): Medication allergy list
170.314 (a)(8): Clinical decision support
170.314 (a)(9): Electronic notes
170.314 (a)(10): Drug formulary checks
170.314 (a)(11): Smoking status
170.314 (a)(12): Image results
170.314 (a)(13): Family health history
170.314 (a)(14): Patient list creation
170.314 (a)(15): Patient-specific education resources
170.314 (b)(1): Transitions of care – receive, display and incorporate transition of care/referral summaries
170.314 (b)(2): Transitions of care – create and transmit transition of care/referral summaries
170.314 (b)(3): Electronic prescribing
170.314 (b)(4): Clinical information reconciliation
170.314 (b)(5)(A): Incorporate laboratory tests and values/results
170.314 (b)(7): Data portability  
170.314 (c)(1): Clinical quality measures – capture and export
170.314 (c)(2): Clinical quality measures – import and calculate  
170.314 (c)(3): Clinical quality measures – electronic submission
170.314 (d)(1): Authentication, access, control, and authorization
170.314 (d)(2): Auditable events and tamper-resistance
170.314 (d)(3): Audit report(s)
170.314 (d)(4): Amendments
170.314 (d)(5): Automatic log-off
170.314 (d)(6): Emergency access
170.314 (d)(7): End-user device encryption
170.314 (d)(8): Integrity
170.314 (e)(1): View, download, and transmit to a 3rd party with edge protocol testing
170.314 (e)(2): Ambulatory setting only -clinical summary
170.314 (e)(3): Ambulatory setting only – secure messaging
170.314 (f)(1): Immunization information  
170.314 (f)(2): Transmission to immunization registries  
170.314 (f)(3): Transmission to public health agencies – syndromic surveillance
170.314 (g)(2): Automated measure calculation
170.314 (g)(3): Safety-enhanced design
170.314 (g)(4): Quality management system

 

Clinical Quality Measures to which ChartAccess® is certified:

CMS62: HIV/AIDS: Medical Visit
CMS68: Documentation of Current Medications in the Medical Record
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS130: Colorectal Cancer Screening
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain

 

Additional software use demonstrate compliance with certification criteria:

DrFirst Rcopia, Intelichart, ExitCare

ONC Disclaimer:

This EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  

Costs & Limitations Transparency:

Upfront costs:

  • Tiered software licensing based on provider or bed quantity at time of purchase
  • Implementation and Training services
  • Basic Support and Maintenance services
  • Hosting or Hardware costs as defined by licensing model


Additional fees which may be incurred include:

  • Training beyond the scope of the original implementation
  • Consulting services for meeting regulatory requirements
  • Level II support services beyond the scope of the licensed product
    • e.g.: infrastructure and network support
  • Maintenance release level updates outside of normal business hours
  • New Software Release Versions which were not included in initial Software licensing
  • New Modular Products not in initial software licensing.
  • New Interface development and maintenance beyond the scope of the original implementation
    • e.g.: interfaces to reporting registries for Meaningful Use measures or any other regulatory reporting
  • Implementation of additional peripheral and other hardware devices beyond the scope of the original implementation
    • e.g.: including but not limited to printers, mobile workstations, scanners, tablets, etc.
  • Prognosis Innovation Healthcare cloud backup solution
  • Software reconfiguration requests outside of the original scope of implementation
  • Revenue Cycle Management services


Costs which may be subject to escalation:

  • Annual support and maintenance fees
  • If applicable, annual hosting fees
  • If applicable, annual subscription fees
  • Annual third party fees such as ePrescribing, Practice Portal, Patient education content, Encoding, Insurance Eligibility and Advanced Beneficiary Notice which may be brokered through Prognosis Innovation Healthcare or contracted directly


Periodic charges for continual right to use of the software:

As defined by licensing model:

  • Tiered subscription pricing based on provider or bed quantity
  • Annual software Support and Maintenance for contracted software licensing

Limitations:

  • Use of the Patient Electronic Access Reporting out of the Patient Portal is limited to the following DirectTrust network HISPs at this time: MaxMD, Nitor Group.
  • If Public Health Reporting is achieved through an HIE then automated measure calculation of this measure may not be possible without new or additional Interface development.
  • Automated measure calculation of Patient Specific Education requires the use of a specific vendor
  • Automated measure calculation of Electronic Prescribing and refill requests requires the use of a specific vendor without a new or additional interface development.
  • On premise Customer facility installations of Prognosis systems must have the ability to connect to the Prognosis datacenter via an Internet connection to access certain features of the system.
  • Customer must establish a Virtual Private Network connection to Prognosis for Support Services to be activated.